Solid-Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery

  • Angew Chem Int Ed Engl. 2025 Jul 28;64(31):e202424118. doi: 10.1002/anie.202424118.
Baoli Ding  #  1 Jiawen Hu  #  1 Rongtian Zhang  #  1 Binyan Shou  1 Mengdie Chen  1 Li Jiang  2 Meng Yuan  2 Bo Yang  1  2  3  4 Qiaojun He  1  2  5  3 Ji Cao  1  2  3 Cheng-Liang Zhu  1  5
Affiliations
  • 1. Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P.R. China.
  • 2. Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, 310018, P.R. China.
  • 3. Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou, 310058, P.R. China.
  • 4. School of Medicine, Hangzhou City University, Hangzhou, 310015, P.R. China.
  • 5. Center for Drug Safety Evaluation and Research, Zhejiang University, Hangzhou, 310058, P.R. China.
  • # Contributed equally.
Abstract

Phenotypic screening offers an effective path for discovering protein degraders, particularly targeting proteins that are poorly characterized or lack sufficient ligand-binding information. Nonetheless, phenotypic protein degrader discovery (PPDD) faces practical hurdles, such as synthetic complexity in generating chemically diverse libraries and difficulties in reliably identifying degradation-driven phenotypes in direct-to-biology (D2B) assays. In response to these challenges, we developed an integrated PPDD platform that combines optimized solid-phase parallel synthesis with a robust D2B screening workflow. Leveraging photocleavable linkers and versatile synthetic strategies, this platform facilitates rapid generation of chemically diverse, ready-to-screen bifunctional molecule libraries requiring minimal purification. As a proof of concept, we synthesized and phenotypically screened 130 cereblon-recruiting molecules, leading to several promising protein degradation-dependent hits. Subsequent hit optimization and target identification validated compound 12-60 as a structurally novel GSPT1 degrader with compelling cellular activity. Overall, our integrated platform represents an efficient and practical toolkit for PPDD, establishing a versatile foundation to accelerate future campaigns and expand the degradable proteome.

Keywords
Molecular glue degrader; PROTAC; Phenotypic protein degrader discovery; Solid‐phase synthesis; Targeted protein degradation.
Products